LXRX CIK: 1062822

Lexicon Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.09
FY22:
0.14
FY23:
0.18
FY24:
0.25
FY25:
0.10
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.05
FY22:
0.05
FY23:
0.05
FY24:
0.05
FY25:
0.08
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.14
FY22:
0.19
FY23:
0.23
FY24:
0.30
FY25:
0.18

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.02
FY22:
0.02
FY23:
0.03
FY24:
0.05
FY25:
0.02
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.00
FY22:
0.05
FY23:
0.10
FY24:
0.11
FY25:
0.06
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.11
FY22:
0.12
FY23:
0.09
FY24:
0.15
FY25:
0.11
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.14
FY22:
0.19
FY23:
0.23
FY24:
0.30
FY25:
0.18

All amounts in billions USD Data source:SEC EDGAR